Design and use of a quantitative scale for measuring presyncope

Journal of Cardiovascular Electrophysiology

Volumn 20, Issue 8, 2009, Pages 888-893

  Sheldon, Robert S ^a   Amuah, Joseph E ^a   Connolly, Stuart J ^b   Rose, Sarah ^a   Morillo, Carlos A ^b   Talajic, Mario ^e   Kus, Teresa ^e   Fouad Tarazi, Fetnat ^f   Klingenheben, Thomas ^c   Krahn, Andrew D ^d   Sheldon, Aaron ^a   Koshman, Mary Lou ^a   Ritchie, Debbie ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Beta blockers; Clinimetrics; Presyncope measurement; Randomized trial; Vasovagal syncope

Indexed keywords

METOPROLOL; PLACEBO;

ADULT; ARTICLE; CALGARY PRESYNCOPE FORM; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MORBIDITY; PRESYNCOPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SYNCOPE; TILT TABLE TEST; TREATMENT DURATION;

ADULT; DOUBLE-BLIND METHOD; EVALUATION STUDIES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METOPROLOL; MIDDLE AGED; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; SYNCOPE; WEIGHTS AND MEASURES; YOUNG ADULT;

EID: 68149108198     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01466.x     Document Type: Article

References (17)

1. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB : Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 1991 44 : 1037 1043.
2. Rose S, Koshman ML, Spreng S, Sheldon RS : The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epi 2000 53 : 1209 1216.
3. Van Dijk N, Sprangers MA, Colman N, Boer KR, Wieling W, Linzer M : Clinical factors associated with quality of life in patients with transient loss of consciousness. J Cardiovasc Electrophysiol 2006 17 : 998 1003.
4. Van Dijk N, Sprangers MA, Boer KR, Colman N, Wieling W, Linzer M : Quality of life within one year following presentation after transient loss of consciousness. Am J Cardiol 2007 100 : 672 676.
5. Van Dijk N, Boer KR, Wieling W, Linzer M, Sprangers MA : Reliability, validity and responsiveness of the syncope functional status questionnaire. J Gen Int Med 2007 22 : 1280 1285.
6. Sheldon RS, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, Talajic M, Kus T, Fouad-Tarazi F, Ritchie D, Koshman ML : The Prevention of Syncope Trial (POST): A randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006 113 : 1164 1170.
7. van Dijk N, Quartieri F, Blanc JJ, Garcia-Civera R, Brignole M, Moya A, Wieling W : PC-trial investigators. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: The physical counterpressure manoeuvres Trial (PC-Trial). J Am Coll Cardiol 2006 48 : 1652 1657.
8. Connolly SJ, Sheldon RS, Roberts RS, Gent M : The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999 33 : 16 20.
9. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M : Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): A randomized trial. J Am Med Assoc 2003 289 : 2224 2229.
10. Salim MA, Di Sessa TG : Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: A double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 2005 45 : 484 488.
11. R Development Core Team 2008). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
12. Ware JE, Snow KK, Kosinski M, Gandek B : SF-36 Health Survey Manual and Interpretation Guide. Boston, MA : The Health Institute, New England Medical Center 1993.
13. Linzer M, Gold DT, Pontinen M, Divine GW, Felder A, Brooks WB : Recurrent syncope as a chronic disease: Preliminary validation of a disease-specific measure of functional impairment. J Gen Intern Med 1994 9 : 181 186.
14. Van Dijk N, Boer KR, Colman N, Bakker A, Stam J, Van Grieken JM, Wilde AAM, Linzer M, Reitsma JB, Wieling W : High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: The fainting assessment study. J Cardiovasc Electrophysiol 2008 19 : 48 55.
15. Sheldon RS, Rose S, Koshman ML : Comparison of patients with syncope of unknown cause having negative or positive tilt table tests. Am J Cardiol 1997 80 : 581 585.
16. Grimm W, Degenhardt M, Hoffmann J, Menz V, Wirths A, Maisch B : Syncope recurrence can be better predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur Heart J 1997 18 : 1465 1469.
17. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Tognarini S, Mont L, Botto G, Giada F, Cornacchia D : Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001 104 : 1261 1267. (Pubitemid 32848115)